( Mended Hearts a nationwide heart patie...)First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America,Health

Mended Hearts, a nationwide heart patient support group affiliated with the American Heart Association. Through distribution and awareness of the report, the diabetes complications consortium hopes to help people with type 2 diabetes, especially those at high risk for developing diabetes-related complications, recognize the importance of controlling their blood sugar levels and working with their doctor to develop a good diabetes management plan.

People can learn more about managing type 2 diabetes and how to reduce the risk of diabetes-related complications by visiting http://www.stateofdiabetes.com.

Type 2 diabetes accounts for 90 to 95 percent of all diagnosed diabetes cases and affects more than 18 million people in the United States. Type 2 diabetes is a chronic, progressive and serious disease that occurs either when the body does not produce enough insulin or when the body does not respond properly to its natural insulin. As a result, sugar builds up in the blood and over time, high levels of blood sugar can lead to a variety of serious diabetes-related complications including: heart disease, stroke, eye damage, kidney disease and foot problems that can lead to amputations.

GlaxoSmithKline has provided funding and other support for the State of Diabetes Complications in America campaign to the American Association of Clinical Endocrinologists and members of the consortium. GlaxoSmithKline, one of the world's leading research-based pharmaceutical and healthcare companies, is committed to improving the quality of human life by enabling people to do more, feel better and live longer.

Note to Editor: To assess the prevalence of complications, data for the State of Diabetes Complications in America report were taken from the National Health and Nutrition Examination Survey (NHANES) 1999-2004, a nationally representative survey of non-institutionalized, U.S. civilians. NHANES
'"/>

Page: 1 2 3 4 5 6 7
Related medicine technology :

1. Largest National U.S. Healthcare Facility MRSA Study Reveals Infection Rates Eight Times Greater Than Previous Estimates
2. Actilyse (alteplase) Recommended by National Institute for Health and Clinical Excellence for Treatment of Acute Ischaemic Stroke
3. Positive Results Prompt US National Cancer Institute to Make Glivec Available to Patients in Post-Surgical GIST Study
4. Positive Results Prompt US National Cancer Institute to Make Gleevec Available To Patients in Post-Surgical Gist Study
5. Research Results on FluMist Presented at National Association of Pediatric Nurse Practitioners Conference
6. Protox Announces Publication in Journal of the National Cancer Institute Supporting PRX302 as Treatment for Prostatic Diseases
7. Calando Pharmaceuticals Publishes the First Non-Human Primate Study on Targeted, Systemic Delivery of siRNA in National Academy of Sciences Journal
8. Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings
9. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
10. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
11. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis